GlassScriptPhysician profile
Christian C Shults
NPI 1083871081
$257,839.92
in general payments reported to CMS, 2019-2025
24 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $7,582 · 2021: $70K · 2022: $32K · 2023: $77K · 2024: $40K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $103K · Travel and Lodging: $23K · Food and Beverage: $5,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $102,547.50 |
| Travel and Lodging | $23,273.68 |
| Food and Beverage | $5,928.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $217,345.66 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Bolton Medical INC | $17,005.01 | 2019-2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid, Gelweave |
| W. L. Gore & Associates, INC. | $10,899.00 | 2019-2024 | Product In Development, Gore Tag Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Edwards Lifesciences Corporation | $2,288.79 | 2019-2025 | Inspiris Resilia Aortic Valve |
| Artivion, INC. | $2,117.72 | 2021-2025 | Amds-Ascyrus Medical |
| Ethicon INC. | $2,047.50 | 2023 | |
| Abbott Laboratories | $1,425.79 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Ensite |
| Medtronic Vascular, INC. | $998.54 | 2019-2020 | |
| Allergan, INC. | $950.16 | 2019 | |
| Getinge USA Sales, LLC | $835.82 | 2021-2025 | Cardiosave Rescue, Cardiosave Hybrid, Type B Plug, Cardiohelp |
| Medtronic, INC. | $656.01 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Abiomed | $525.95 | 2022-2025 | Impella |
| Boston Scientific Corporation | $185.47 | 2019-2023 | Watchman Flx |
| Cook Medical LLC | $120.82 | 2022 | |
| Intuitive Surgical, INC. | $110.47 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jenavalve Technology, INC. | $93.68 | 2022 | |
| Angiodynamics, INC. | $69.24 | 2024 | Angiovac |
| Zimmer Biomet Holdings, INC. | $38.48 | 2019 | |
| Janssen Pharmaceuticals, INC | $38.00 | 2022 | |
| Impulse Dynamics (USA) INC. | $37.59 | 2023 | Optimizer |
| Werfen USA LLC | $20.63 | 2023 | |
| Ethicon US, LLC | $17.46 | 2024 | Evarrest, Vistaseal, Surgicel Nu-Knit |
| Hemosonics LLC | $12.13 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Shults listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.